in Great Hall A of the Ernest N
At present, Alkem Laboratories, Dr Reddy's Laboratories and Sun Pharma have secured regulatory approvals in India, while other players await clearance, the report noted
Graphical Abstract Similar content being viewed by others Burden of chronic kidney disease in type 1 diabetes: an unmet clinical need Similar to type 2 diabetes, hyperglycaemia in type 1 diabetes increases the risk of end-organ damage, including chronic kidney disease (CKD)
Effects of prolonged exendin-4 administration on hypothalamic-pituitary-adrenal axis activity and water balance
17 If a patient is already on a potent inhibitor of CYP2D6 (paroxetine, fluoxetine), in general, it is advisable to switch to another SSRI or a serotonin norepinephrine reuptake inhibitor (SNRI) that has less potential for interaction
Will I need to stay on this medicine indefinitely